Support women in science at Burnet Institute
Donate today to support women in science at Burnet and their work to unlock the vaginal microbiome and reduce risk of HIV infection and preterm birth for women around the world.
Donate today to support women in science at Burnet and their work to unlock the vaginal microbiome and reduce risk of HIV infection and preterm birth for women around the world.
By understanding the causes of persistent immune activation and chronic inflammation in HIV patients, we aim to develop prognostic tools and adjunctive therapies to predict and improve health outcomes.
HIV infection is a chronic viral infection which can be managed using combination antiretroviral therapy such that progression to AIDS is greatly minimised. Long term management of patients receiving antiretroviral therapy, especially their risk of non-AIDS co-morbidities, is a major concern.
Our group focuses on understanding the immune defects that persist in HIV+ patients receiving combination antiretroviral therapy, and how these contribute to decreased life expectancy and increased non-AIDS co-morbidities such as cardiovascular disease.
By understanding the causes of persistent immune activation and chronic inflammation in HIV patients, we aim to develop prognostic tools and adjunctive therapies to predict and improve health outcomes.
We study cells of the innate immune system (monocytes and natural killer cells) that are important to inflammation.
Deputy Program Director, Disease Elimination